Involved in 20 projects, with the CEA acting as co-ordinator for 4 of these :

• Actinet unites the top teams specialising in the science of actinides, from 27 different European organisations, who, via this network, pursue joint research activities, share equipment and procedures, and set up specialised training programmes. » Access to the Actinet website.

• Emil : molecular imaging is one of the best methods used to diagnose and monitor the treatment of cancer. Emil, which groups together 58 European laboratories representing 13 countries, i.e. a network of around 450 researchers, aims to co-ordinate all research in this sector and thus develop a virtual centre of excellence that will be unique in Europe. »Access to the Emil website.

• Neuroprions , on prion diseases with applied research on diagnosis methods and expertise in activities relative to risk analysis with regard to public health and the environment. It unites a total of 52 laboratories from 20 countries. » Access to the Neuroprion website.

• Nano2life : Its objective is to integrate existing European expertise in the field of nano- biotechnologies and to make Europe more competitive, including in terms of industry transfer. It unites 23 centres or regions, with recognised experience in implementing programmes in the area of nano-biotechnologies. A group of 21 private high-tech companies is also associated with this network. » Access to the Nanolife website.

Involved in 56 projects, acting as co-ordinator for 5 of these:

• Maestro, steered by the Technological Research Division's Technology Systems Integration Laboratory (LIST/DRT), its objective is to improve the precision of cancer therapy using radiation.
• Nanosafe2, aimed at implementing an industrial strategy concerning the management of potential risks related to the production and use of certain nanoparticles.
• Europart, works on the emergence of new molecular architectures for the separation of long-life radioelements with 24 partners.
• Perfect , works on predicting the effects of radiation on the component parts of nuclear reactors.
• Risc-rad. Project Risc-Rad unites European research in the field of radiobiology: studies range from DNA lesions to radiation-induced cancer. It groups together 33 European laboratories representing 11 countries, forming a network of around 400 researchers

involved in 10 projects, acting as co-ordinator for 3 of these:

• Ilias : Ilias unites European researchers specialising in astroparticle physics , a recently developed field of scientific research, which draws on particle physics and cosmology . It unites 20 institutes representing 70 laboratories. » Access to the Ilias website.

• Care : Care unites 22 participants and 58 associated institutes. Its objective is to improve the performance of accelerators by producing technical studies, and even prototypes, of the different accelerator components. » Access to the Care website.

• MNT Europe : MNT Europe's objective is to integrate the research capacities and equipment in the field of micro and nanotechnologies possessed by the 5 major research organisations in Europe focused on microelectronices and micro-nanotechnologies.

The CEA will have a presence on the Researcher's Mobility portal, set up by the EU and featuring information on job vacancies, thesis and doctorate opportunities within the European Research Area.

The CEA and preparations for the FP7, the 7th R&D Framework Programme

The CEA is playing an active role in preparations for the FP7 – the 7th R&D Framework Programme and, in particular, is involved in the technology platforms set up by the European Commission. These technology platforms, will bring together key European players in a specific field (industrialists, researchers, users, public authorities, etc.) based on a common strategic vision.

In particular, the CEA is involved in the following technology platforms :

• Hydrogen and fuel cells
• Nanoelectronics
• Embedded system